Every Form 4 that SkinHealth Systems Inc. (SKIN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SKIN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SKIN filings page.
SkinHealth Systems Inc. Chief Financial Officer Michael P. Monahan reported a Form 4 transaction involving 32,357 shares of Class A Common Stock on 2026-08-10. The shares were withheld by the issuer to satisfy tax withholding requirements upon vesting of restricted stock units, and the disclosure states this does not represent a sale. Following this tax-withholding disposition, Monahan directly holds 1,955,280 shares of Class A Common Stock.
Beauty Health Co executive Sheri Lewis, the CSO and COO, reported a tax-related share disposition. On April 9, 2026, 24,904 shares of Class A common stock, valued at $0.92 per share, were withheld by the company to cover taxes on vesting restricted stock units.
After this withholding, Lewis directly holds 1,584,620 shares of Class A common stock. A footnote clarifies that this was solely to satisfy tax withholding requirements and does not represent an open-market sale of shares.
Beauty Health Co Chief Financial Officer Michael P. Monahan had 26,776 shares of Class A Common Stock withheld by the company to cover tax obligations on vested restricted stock units. The shares were valued at $0.92 per share for this tax-withholding transaction.
After this non-market disposition, which the company states does not represent a sale, Monahan directly holds 1,987,637 shares of Beauty Health Co Class A Common Stock.
Malha Pedro Bruno Ferreira reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that President and CEO Pedro Bruno Ferreira Malha received a grant of 2,654,867 restricted stock units (RSUs) of Class A Common Stock as equity compensation. Each RSU represents one share of stock and vests in three equal annual installments starting on the first anniversary of the March 20, 2026 grant date, subject to continued service and certain acceleration rights.
After this award, Malha is shown as beneficially owning 4,845,251 shares of Class A Common Stock directly. The transaction was recorded at a price of $0.00 per share, reflecting that it is a compensation grant rather than an open-market purchase.
MONAHAN MICHAEL P. reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that Chief Financial Officer Michael P. Monahan received a grant of 746,681 restricted stock units of Class A Common Stock. These RSUs vest in three equal annual installments starting on March 20, 2026, contingent on continued service and certain acceleration provisions. Following this award, Monahan directly holds 2,014,413 shares or share-equivalent units, reflecting a compensation-related equity grant rather than an open-market transaction.
Menezes Ronald reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that Chief Revenue Officer Ronald Menezes received a large equity grant in the form of restricted stock units (RSUs). He was awarded 746,681 RSUs of Class A Common Stock at no purchase price as part of his compensation.
Each RSU represents a future right to receive one share of Class A Common Stock, subject to time-based vesting. The award vests in three equal installments on each of the first three anniversaries of the March 20, 2026 grant date, contingent on continued service and certain acceleration rights. Following this grant, Menezes directly owns 1,759,915 shares of the company’s Class A Common Stock.
Beauty Health Co reported that CSO and COO Sheri Lewis received an equity compensation grant of 746,681 restricted stock units (RSUs) of Class A Common Stock. Each RSU represents a contingent right to receive one share, subject to time-based vesting and continued service conditions.
The RSUs vest in three equal installments on each of the first three anniversaries of the March 20, 2026 grant date, with certain acceleration rights. Following this grant, Lewis beneficially owns 1,609,524 shares of Class A Common Stock directly, reflecting a large, compensation-related, non-market acquisition rather than an open-market purchase.
Beauty Health Co executive Sheri Lewis reported a routine tax-related share disposition. On March 17, she had 51,883 shares of Class A common stock withheld by the company at $1.17 per share to cover tax obligations on vesting restricted stock units. The footnote clarifies this was not an open-market sale, and she still directly holds 862,843 shares after the transaction.
Beauty Health Co Chief Revenue Officer reports tax share withholding. Ronald Menezes had 61,471 shares of Class A Common Stock withheld at $1.17 per share on March 17, 2026 to cover taxes on vesting restricted stock units. After this non-sale disposition, he directly holds 1,013,234 shares.
Beauty Health Co Chief Financial Officer Michael P. Monahan reported a tax-related share disposition tied to vesting of restricted stock units. The filing shows 58,573 shares of Class A Common Stock valued at $1.17 per share were withheld by the company to satisfy tax withholding requirements and explicitly notes this does not represent a sale in the market. After this withholding, Monahan directly holds 1,267,732 shares of Class A Common Stock, indicating he retains a substantial equity position following the RSU vesting event.
The Beauty Health Company (SKIN) reported an equity award to one of its directors. On 11/13/2025, the director received 57,692 restricted stock units (RSUs) of Class A common stock. Each RSU represents a contingent right to receive one share, subject to time-based vesting conditions. The RSUs vest on the earlier of the one-year anniversary of the grant date and the date of the Company’s 2026 Annual Meeting of Stockholders, as long as the director continues to serve on the board through that time. Following this grant, the director beneficially owns 57,692 Class A shares directly.
Beauty Health Co (SKIN) reporting person Pedro Bruno Ferreira Malha, who is President, CEO and a director, received restricted stock unit grants on 10/09/2025 that total 2,190,384 Class A common shares when combined across two grant lines. The filing shows 1,228,846 and 961,538 RSUs granted at an indicated per-share figure of $1.56. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant, subject to continued service and certain acceleration rights, and are reported as directly owned following the grant.
The report was signed by an attorney-in-fact on 10/10/2025. No derivative securities or other transactions are disclosed. This filing documents an equity grant to align the CEO/director with shareholder interests through multi-year vesting rather than a sale or purchase of existing shares.